Mechanisms governing metastatic dormancy and reactivation
- PMID: 24209616
- PMCID: PMC4354734
- DOI: 10.1016/j.cell.2013.10.029
Mechanisms governing metastatic dormancy and reactivation
Abstract
Many cancer patients suffer from metastatic relapse several years after they have undergone radical surgery. Early cancer cell dissemination followed by a protracted period of dormancy potentially explains this prevalent clinical behavior. Increasing evidence suggests that the metastasis-initiating cells are cancer stem cells or revert to this functional state upon infiltrating a target organ. Their entry into dormancy and subsequent reactivation are governed by intrinsic programs and by contextual cues, which resemble those regulating the self-renewal capability of adult stem cells. In addition, metastatic cells undergoing reactivation are nursed by specialized extracellular matrix niches, which support positive signals, such as Wnt and Notch, and attenuate negative signals, such as BMP. In spite of significant remaining uncertainties, these findings provide a framework to understand the logic of metastatic dormancy and reactivation and open new avenues for therapeutic intervention.
Copyright © 2013 Elsevier Inc. All rights reserved.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4354734/bin/nihms666054f1.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4354734/bin/nihms666054f2.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4354734/bin/nihms666054f3.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4354734/bin/nihms666054f4.gif)
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4354734/bin/nihms666054f5.gif)
![Figure 6](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4354734/bin/nihms666054f6.gif)
![Figure 7](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4354734/bin/nihms666054f7.gif)
Similar articles
-
The Extracellular Matrix Modulates the Metastatic Journey.Dev Cell. 2019 May 6;49(3):332-346. doi: 10.1016/j.devcel.2019.03.026. Dev Cell. 2019. PMID: 31063753 Free PMC article. Review.
-
Cancer Metastasis: A Reappraisal of Its Underlying Mechanisms and Their Relevance to Treatment.Annu Rev Pathol. 2018 Jan 24;13:117-140. doi: 10.1146/annurev-pathol-020117-044127. Epub 2017 Oct 25. Annu Rev Pathol. 2018. PMID: 29068753 Review.
-
Metastatic dormancy: a complex network between cancer stem cells and their microenvironment.Histol Histopathol. 2014 Dec;29(12):1499-510. doi: 10.14670/HH-29.1499. Epub 2014 Jun 2. Histol Histopathol. 2014. PMID: 24887025 Review.
-
Metastatic stem cells: sources, niches, and vital pathways.Cell Stem Cell. 2014 Mar 6;14(3):306-21. doi: 10.1016/j.stem.2014.02.002. Cell Stem Cell. 2014. PMID: 24607405 Free PMC article. Review.
-
Extracellular matrix: a gatekeeper in the transition from dormancy to metastatic growth.Eur J Cancer. 2010 May;46(7):1181-8. doi: 10.1016/j.ejca.2010.02.027. Epub 2010 Mar 19. Eur J Cancer. 2010. PMID: 20304630 Free PMC article. Review.
Cited by
-
Iron metabolism: backfire of cancer cell stemness and therapeutic modalities.Cancer Cell Int. 2024 May 4;24(1):157. doi: 10.1186/s12935-024-03329-x. Cancer Cell Int. 2024. PMID: 38704599 Free PMC article. Review.
-
Identification and validation of a novel anoikis-related prognostic model for prostate cancer.Mol Genet Genomic Med. 2024 Apr;12(4):e2419. doi: 10.1002/mgg3.2419. Mol Genet Genomic Med. 2024. PMID: 38572916 Free PMC article.
-
β-hydroxybutyrate inhibits malignant phenotypes of prostate cancer cells through β-hydroxybutyrylation of indoleacetamide-N-methyltransferase.Cancer Cell Int. 2024 Mar 30;24(1):121. doi: 10.1186/s12935-024-03277-6. Cancer Cell Int. 2024. PMID: 38555451 Free PMC article.
-
Research Progress of Plant-Derived Natural Products against Drug-Resistant Cancer.Nutrients. 2024 Mar 11;16(6):797. doi: 10.3390/nu16060797. Nutrients. 2024. PMID: 38542707 Free PMC article. Review.
-
Extracellular vesicle-mediated transfer of miRNA-1 from primary tumors represses the growth of distant metastases.Exp Mol Med. 2024 Mar;56(3):734-746. doi: 10.1038/s12276-024-01181-7. Epub 2024 Mar 27. Exp Mol Med. 2024. PMID: 38531964 Free PMC article.
References
-
- Aguirre-Ghiso JA, Estrada Y, Liu D, Ossowski L. ERK(MAPK) activity as a determinant of tumor growth and dormancy; regulation by p38(SAPK) Cancer Res. 2003;63:1684–1695. - PubMed
-
- Alvarez-Buylla A, Lim DA. For the long run: maintaining germinal niches in the adult brain. Neuron. 2004;41:683–686. - PubMed
-
- Asselin-Labat ML, Sutherland KD, Vaillant F, Gyorki DE, Wu D, Holroyd S, Breslin K, Ward T, Shi W, Bath ML, et al. Gata-3 negatively regulates the tumor-initiating capacity of mammary luminal progenitor cells and targets the putative tumor suppressor caspase-14. Mol. Cell. Biol. 2011;31:4609–4622. - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources